Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News


ADHD & the brain: Does ADHD treatment improve long-term academic, social and behavioral outcomes?


The ADHD challenge

The core symp­toms of ADHD fre­quent­ly cause sig­nif­i­cant impair­ment in aca­d­e­m­ic, social and behav­ioral func­tion­ing that adverse­ly impact indi­vid­u­als’ qual­i­ty of life. These symp­toms often per­sist into adult­hood, poten­tial­ly com­pro­mis­ing an indi­vid­u­al’s func­tion­ing over many years. Under­stand­ing how ADHD impacts long-term func­tion­ing, and whether adverse long-term affects are dimin­ished with treat­ment, is thus extreme­ly impor­tant. How­ev­er, despite ample evi­dence that treat­ments such as med­ica­tion and behav­ior ther­a­py yield sub­stan­tial short-term ben­e­fits for most indi­vid­u­als, the impact of treat­ment on longer-term out­comes remains less well-estab­lished. This is an impor­tant gap in the research lit­er­a­ture.

In last mon­th’s issue of Atten­tion Research Update I reviewed a paper that syn­the­sized research on long-term aca­d­e­m­ic out­comes for youth with ADHD. Key find­ings were that aca­d­e­m­ic out­comes were gen­er­al­ly bet­ter for treat­ed vs. untreat­ed youth, but gen­er­al­ly remained sig­nif­i­cant­ly below out­comes attained by youth with­out ADHD.

What about the impact of ADHD and ADHD treat­ment on long-term out­comes in oth­er impor­tant domains such as social and occu­pa­tion­al func­tion­ing, anti­so­cial behav­ior and sub­stance use, dri­ving, and self-esteem? Is there evi­dence that treat­ment helps? Does it help enough to nor­mal­ize out­comes rel­a­tive to those with­out ADHD?

The evidence review

These impor­tant issues were addressed in a paper titled ‘A sys­tem­at­ic review and analy­sis of long-term out­comes in atten­tion deficit hyper­ac­tiv­i­ty dis­or­der: Effects of treat­ment and non-treat­ment’. The paper was pub­lished in 2012 in BMC Med­i­cine.

The authors began by search­ing for rel­e­vant stud­ies pub­lished between 1980 and 2010. All stud­ies com­pared out­comes in par­tic­i­pants with and with­out ADHD or between treat­ed and untreat­ed par­tic­i­pants with ADHD. A total of 351 stud­ies were iden­ti­fied; these includ­ed lon­gi­tu­di­nal stud­ies where indi­vid­u­als were fol­lowed for at least 2 years and cross-sec­tion­al stud­ies where out­comes were mea­sured in groups of par­tic­i­pants at dif­fer­ent ages. Only stud­ies where out­comes were assessed in indi­vid­u­als at least 10-years old were includ­ed. The ages of par­tic­i­pants in these stud­ies extend­ed from chil­dren to old­er adults.

It is impor­tant to note that the stud­ies includ­ed were quite var­ied and have dif­fer­ent method­olog­i­cal strengths and weak­ness­es. And, many were not ‘long-term’ in the sense of fol­low­ing indi­vid­u­als diag­nosed in child­hood to learn how they were doing as young adults; instead, the authors chose to define ‘long-term’ as 2 years or more. These issues are prob­lem­at­ic, but being more restric­tive on the stud­ies includ­ed would have intro­duce dif­fer­ent chal­lenges, e.g., too few stud­ies to ana­lyze. Thus, lim­i­ta­tions in what can be con­clud­ed from the authors work are inevitable and reflect lim­i­ta­tions in the stud­ies they had to draw on.

As not­ed above, 351 stud­ies were includ­ed for analy­sis. Many of these stud­ies includ­ed more than one out­come, so the num­ber of out­comes com­pared exceed­ed this total. Nine dif­fer­ent types of out­comes were exam­ined. These out­comes, and the num­ber of stud­ies in which each was exam­ined, are as fol­lows:

  1. Drug use/addictive behav­ior — 160 stud­ies
  2. Aca­d­e­m­ic out­comes — 119 stud­ies
  3. Anti­so­cial behav­ior — 104 stud­ies
  4. Social func­tion­ing — 98 stud­ies
  5. Occu­pa­tion­al func­tion­ing — 45 stud­ies
  6. Self-esteem — 44 stud­ies
  7. Dri­ving out­comes — 30 stud­ies
  8. Ser­vice use (emer­gency health care, finan­cial assis­tance) — 26 stud­ies
  9. Obe­si­ty — 10 stud­ies

Across all stud­ies, the aver­age length of time for which researchers col­lect­ed data on par­tic­i­pants was 9 years; the range of time for which data was col­lect­ed was 2 years to 40 years. As not­ed above, the stud­ies includ­ed par­tic­i­pants across a wide age-range.

The Results

Com­par­ing results across such dis­parate stud­ies is com­pli­cat­ed, par­tic­u­lar­ly giv­en the vari­ety of out­comes exam­ined and the mea­sures used to exam­ine them. This makes it chal­leng­ing to com­bine results across stud­ies into a sin­gle analy­sis, as is fre­quent­ly done in meta-ana­lyt­ic work. As an alter­na­tive, the authors count­ed how often out­comes were sig­nif­i­cant­ly dif­fer­ent between the groups com­pared in each study, e.g., youth with and with­out ADHD or treat­ed vs. untreat­ed youth with ADHD. They then count­ed the num­ber of times that out­comes were found to be sig­nif­i­cant­ly dif­fer­ent.

For exam­ple, if dri­ving out­comes were com­pared between treat­ed vs. untreat­ed indi­vid­u­als with ADHD in 22 stud­ies, they count­ed how many times the out­come was sig­nif­i­cant­ly bet­ter for treat­ed indi­vid­u­als and how many times there was no sig­nif­i­cant dif­fer­ence.

Out­comes com­par­ing indi­vid­u­als with untreat­ed ADHD to peers

A total of 333 stud­ies com­pared out­comes between untreat­ed par­tic­i­pants with ADHD and con­trols; in many of these stud­ies, mul­ti­ple out­comes were com­pared. Over­all, out­comes for indi­vid­u­als with untreat­ed ADHD were sig­nif­i­cant­ly worse than for com­par­i­son sub­jects approx­i­mate­ly 75% of the time. Infor­ma­tion on whether this var­ied sig­nif­i­cant­ly across dif­fer­ent out­comes, and how much worse out­comes for untreat­ed par­tic­i­pants tend­ed to be, was not pro­vid­ed. Thus, one can’t con­clude much from this sum­ma­ry beyond the fact that indi­vid­u­als with untreat­ed ADHD tend to fare worse over the long-term in mul­ti­ple domains rel­a­tive to those with­out ADHD.

Out­comes with ADHD treat­ment

Treat­ed vs. untreat­ed ADHD was com­pared in 48 stud­ies involv­ing 76 out­comes. For 72% of the out­comes, treat­ed indi­vid­u­als were doing sig­nif­i­cant­ly bet­ter. For the remain­ing 28% of out­comes, treat­ed and untreat­ed indi­vid­u­als gen­er­al­ly did not dif­fer although in rare instances treat­ed indi­vid­u­als were doing worse.

The like­li­hood that treat­ment was linked was linked to bet­ter out­come var­ied con­sid­er­ably across the dif­fer­ent out­comes exam­ined. Treat­ed indi­vid­u­als did bet­ter than untreat­ed indi­vid­u­als for 100% of dri­ving and obe­si­ty out­comes, 90% of self-esteem out­comes, 83% of social func­tion­ing out­comes, 71% of aca­d­e­m­ic out­comes, 67% of drug use out­comes, 50% of anti­so­cial behav­ior out­comes, 50% of ser­vice use out­comes, and 33% of occu­pa­tion­al out­comes.

Thus, for all out­comes except for anti­so­cial behav­ior, ser­vice use, and occu­pa­tion­al func­tion­ing, treat­ed indi­vid­u­als were like­ly to be doing bet­ter. For the lat­ter 3 out­comes, how­ev­er, treat­ed indi­vid­u­als were doing bet­ter between one-third and one-half of the time, and about the same the rest of the time.

It is impor­tant to note that treat­ment var­ied across stud­ies and deter­min­ing the qual­i­ty of treat­ment received was not pos­si­ble. In most stud­ies, par­tic­i­pants received med­ica­tion treat­ment; how­ev­er, non-med­ical treat­ment and treat­ment that com­bined med­ica­tion with oth­er treat­ments were also com­mon. Treat­ment type did not seem to be asso­ci­at­ed with the like­li­hood of bet­ter out­comes but details on this were not pro­vid­ed.

Does treatment normalize outcomes?

The results above sug­gest that ADHD treat­ment is gen­er­al­ly asso­ci­at­ed with bet­ter out­comes. How­ev­er, is treat­ment like­ly to nor­mal­ize out­comes rel­a­tive to indi­vid­u­als with­out ADHD?

This was exam­ined in 42 stud­ies that includ­ed 76 dif­fer­ent out­comes. In most cas­es, out­comes were not nor­mal­ized with treat­ment, mean­ing that indi­vid­u­als with ADHD were doing sig­nif­i­cant­ly worse than com­par­i­son sub­jects. This was found for 58 of the 76 out­comes exam­ined. Thus, equiv­a­lent out­comes between treat­ed par­tic­i­pants and con­trols were found only 18 times.

An impor­tant cau­tion

The above results sug­gest that treat­ment gen­er­al­ly pro­vides long-term ben­e­fits to indi­vid­u­als with ADHD but that it does not typ­i­cal­ly ‘nor­mal­ize’their out­comes. Because the stud­ies con­sid­ered by the authors includ­ed ones from both North Amer­i­ca (US + Cana­da) and Europe, the authors also exam­ined whether treat­ment out­comes var­ied geo­graph­i­cal­ly. It appears that they did.

Specif­i­cal­ly, 86% of out­comes for stud­ies con­duct­ed in Europe were con­sis­tent with treat­ment ben­e­fits com­pared to only 50% of out­comes for North Amer­i­can stud­ies. This may be because North Amer­i­can stud­ies tend­ed to use prospec­tive designs in which indi­vid­u­als with ADHD who did vs. did not receive treat­ment were fol­lowed over time while Euro­pean stud­ies were typ­i­cal­ly ret­ro­spec­tive stud­ies of adults. The for­mer would gen­er­al­ly be con­sid­ered a stronger design so one pos­si­ble inter­pre­ta­tion is that more rig­or­ous stud­ies were less like­ly to doc­u­ment long-term ben­e­fits of ADHD treat­ment.

Summary and implications

The authors’ ambi­tious goal in this paper was to sum­ma­ry exist­ing research on long-term out­comes asso­ci­at­ed with ADHD to address 3 fun­da­men­tal ques­tions:

  1. With­out treat­ment, how often do indi­vid­u­als with ADHD expe­ri­ence sig­nif­i­cant­ly worse out­comes than those with­out the dis­or­der?
  2. Is there evi­dence that ADHD treat­ment improves long-term out­comes? And,
  3. Is there evi­dence that ADHD treat­ment gen­er­al­ly nor­mal­izes out­comes?

To address these ques­tions, they iden­ti­fied over 350 stud­ies con­duct­ed in North Amer­i­ca and Europe in which diverse out­comes were exam­ined over at least a 2‑year peri­od. A wide mix of stud­ies and ages were includ­ed, and detailed infor­ma­tion on the type, dura­tion, and qual­i­ty of ADHD treat­ment was not pro­vid­ed (although this may be exam­ined in sub­se­quent work). While this makes it dif­fi­cult if not impos­si­ble to draw firm con­clu­sions, the pat­tern of results obtained con­verge on the fol­low­ing:

  1. With­out treat­ment, the major­i­ty of indi­vid­u­als with ADHD attain sig­nif­i­cant­ly poor­er out­comes in mul­ti­ple domains rel­a­tive to peers.
  2. Treat­ment gen­er­al­ly results in more pos­i­tive out­comes rel­a­tive to no treat­ment, par­tic­u­lar­ly for dri­ving, obe­si­ty, self-esteem, and social func­tion­ing. The con­sis­tent­ly pos­i­tive results found for obe­si­ty may reflect the appetite sup­press­ing effects of stim­u­lant med­ica­tion. Anti­so­cial behav­ior and occu­pa­tion­al out­comes were less like­ly to show ben­e­fits with treat­ment.
  3. Although ADHD treat­ment gen­er­al­ly results in bet­ter long-term out­comes rel­a­tive to no treat­ment, even with treat­ment out­comes are typ­i­cal­ly not nor­mal­ized. Thus, most indi­vid­u­als with ADHD con­tin­ue to be doing less well in mul­ti­ple domains than their peers.

As not­ed above, lim­i­ta­tions in the research base that the authors had to drawn on lim­its any con­clu­sions that can be made about the long-term impact of ADHD treat­ment. In addi­tion, the authors did not con­sid­er how dif­fer­ent types of treat­ment or dura­tion of treat­ment effect­ed treat­ment out­comes, although they indi­cate plans to do this in sub­se­quent work. They also did not dis­cuss the mag­ni­tude of treat­ment effects, which makes it dif­fi­cult to know how often sta­tis­ti­cal­ly sig­nif­i­cant dif­fer­ences between treat­ed and untreat­ed indi­vid­u­als were like­ly to be clin­i­cal­ly mean­ing­ful.

Thus, despite the sig­nif­i­cant effort rep­re­sent­ed by this paper, impor­tant ques­tions remain about the long-term impact of ADHD treat­ment. In fact, the authors con­clude their paper by stat­ing that the “…ques­tion remains as to whether the short-term ben­e­fits demon­strat­ed by short-term drug or non-phar­ma­co­log­i­cal treat­ment stud­ies trans­late into long-term out­comes.”

Hope­ful­ly, sub­se­quent work by these authors and oth­ers in the field will soon pro­vide a more defin­i­tive answer to this basic and impor­tant ques­tion.

Rabiner_David– Dr. David Rabin­er is a child clin­i­cal psy­chol­o­gist and Direc­tor of Under­grad­u­ate Stud­ies in the Depart­ment of Psy­chol­ogy and Neu­ro­science at Duke Uni­ver­sity. He pub­lishes Atten­tion Research Update, an online newslet­ter that helps par­ents, pro­fes­sion­als, and edu­ca­tors keep up with the lat­est research on ADHD, and teach­es the online course  How to Nav­i­gate Con­ven­tional and Com­ple­men­tary ADHD Treat­ments for Healthy Brain Devel­op­ment.

Learn more:

Leave a Reply...

Loading Facebook Comments ...

Leave a Reply

Categories: Attention and ADD/ADHD, Cognitive Neuroscience, Education & Lifelong Learning

Tags: , , , , , , , , , ,

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)